P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849816.07364.24 |
| _version_ | 1797285898483662848 |
|---|---|
| author | N. Shah D. Ayers S. Cope K. Karampampa K. Towle J. Braverman A. Mojebi C. Caisip D. Dhanda |
| author_facet | N. Shah D. Ayers S. Cope K. Karampampa K. Towle J. Braverman A. Mojebi C. Caisip D. Dhanda |
| author_sort | N. Shah |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:10:05Z |
| format | Article |
| id | doaj.art-e10ca053122e4e568039031d271957b1 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:10:05Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-e10ca053122e4e568039031d271957b12024-03-02T07:47:27ZengWileyHemaSphere2572-92412022-06-0161621162210.1097/01.HS9.0000849816.07364.24202206003-01621P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDYN. Shah0D. Ayers1S. Cope2K. Karampampa3K. Towle4J. Braverman5A. Mojebi6C. Caisip7D. Dhanda81 University of California San Francisco, San Francisco, CA, United States of America2 PRECISIONheor, Vancouver, BC, Canada2 PRECISIONheor, Vancouver, BC, Canada3 Bristol Myers Squibb, Princeton, NJ, United States of America2 PRECISIONheor, Vancouver, BC, Canada3 Bristol Myers Squibb, Princeton, NJ, United States of America2 PRECISIONheor, Vancouver, BC, Canada2 PRECISIONheor, Vancouver, BC, Canada3 Bristol Myers Squibb, Princeton, NJ, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000849816.07364.24 |
| spellingShingle | N. Shah D. Ayers S. Cope K. Karampampa K. Towle J. Braverman A. Mojebi C. Caisip D. Dhanda P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY HemaSphere |
| title | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_full | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_fullStr | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_full_unstemmed | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_short | P1740: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH IDECABTAGENE VICLEUCEL VS BELANTAMAB MAFODOTIN: A MATCHING-ADJUSTED INDIRECT COMPARISON STUDY |
| title_sort | p1740 health related quality of life in patients with relapsed refractory multiple myeloma rrmm treated with idecabtagene vicleucel vs belantamab mafodotin a matching adjusted indirect comparison study |
| url | http://journals.lww.com/10.1097/01.HS9.0000849816.07364.24 |
| work_keys_str_mv | AT nshah p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT dayers p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT scope p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT kkarampampa p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT ktowle p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT jbraverman p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT amojebi p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT ccaisip p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy AT ddhanda p1740healthrelatedqualityoflifeinpatientswithrelapsedrefractorymultiplemyelomarrmmtreatedwithidecabtagenevicleucelvsbelantamabmafodotinamatchingadjustedindirectcomparisonstudy |